|
Market Closed -
Nasdaq
00:00:00 29/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 794.19 USD | -1.67% |
|
-4.78% | +2.89% |
| 08-27 | AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial | RE |
| 08-25 | Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.67% | -4.78% | +14.20% | +29.18% | +2.89% | +36.76% | -4.34% | +19.73% | +98.86% | 79.3B | |
| -0.90% | +2.39% | +34.55% | +78.37% | -0.19% | -19.06% | -35.50% | -44.60% | +58.57% | 59.21B | |
| -3.35% | -4.92% | +153.24% | +192.41% | +367.92% | +472.81% | +18.97% | -63.90% | - | 55.09B | |
| -6.78% | -4.19% | +0.47% | +9.02% | -12.33% | -3.45% | +28.35% | +2.06% | - | 49.86B | |
| -2.43% | -2.35% | -13.71% | -13.98% | -9.26% | +8.33% | +160.40% | +122.19% | +194.56% | 47.9B | |
| -1.35% | +0.79% | +4.43% | +11.48% | +24.15% | +65.25% | -18.47% | -36.33% | -28.63% | 32.28B | |
| -2.64% | -2.69% | -2.15% | +28.56% | +25.92% | +46.99% | +92.55% | +64.34% | +52.92% | 25.21B | |
| -0.09% | +4.98% | +19.84% | +28.97% | +40.98% | +11.00% | +199.86% | +76.66% | - | 23.87B | |
| -0.34% | +1.35% | -1.48% | +5.43% | +40.08% | +62.33% | +122.21% | +143.45% | +366.20% | 16.89B | |
| +2.73% | 0.00% | +47.26% | +12.74% | -7.45% | -5.13% | +831.69% | +514.02% | +7,580.00% | 16.17B | |
| -2.64% | -6.01% | -8.31% | +15.61% | +0.14% | +47.99% | +150.98% | +51.74% | - | 14.97B | |
| -0.96% | -3.05% | +5.37% | +12.87% | +8.81% | +10.97% | -31.56% | -22.57% | -32.46% | 12.52B | |
| -3.51% | -4.21% | -12.49% | -15.12% | +8.97% | +64.10% | +153.88% | +729.25% | +2,607.76% | 10.42B | |
| -1.68% | +1.41% | -3.25% | +13.73% | +42.56% | +137.96% | +179.65% | +505.97% | - | 10.4B | |
| -7.66% | -2.89% | +65.41% | +111.43% | +345.71% | +424.21% | +565.94% | +26.70% | - | 8.87B | |
| -1.04% | +0.38% | -3.91% | +7.22% | -7.01% | -17.56% | -21.96% | -51.58% | -47.85% | 6.91B | |
| -1.40% | +2.85% | +3.33% | +34.62% | +3.39% | -3.50% | +63.86% | -11.18% | - | 6.23B | |
| -2.16% | -1.20% | -3.51% | +61.39% | +89.28% | +133.14% | +346.43% | +510.48% | - | 6.09B | |
| -3.10% | -0.72% | +3.12% | -12.38% | -32.42% | -48.21% | -40.52% | -74.04% | - | 5.71B | |
| -2.38% | -10.66% | +3.08% | -4.21% | +3.62% | +17.35% | +213.49% | +212.86% | - | 5.67B | |
| Average | -2.17% | -0.65% | +15.28% | +30.37% | +46.79% | +72.11% | +148.80% | +133.76% | +1,084.99% | 24.68B | |
| Weighted average by Cap. | -2.29% | -1.84% | +25.63% | +43.21% | +53.61% | +80.63% | +87.94% | +63.69% | +574.34% |
- Stock Market
- Stocks
- REGN Stock
- Sector Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
